Source link : https://newshealth.biz/health-news/etrasimod-shows-promise-in-eosinophilic-esophagitis/
TOPLINE: Etrasimod, a once-daily oral selective sphingosine-1-phosphate receptor modulator, is well tolerated and effective in treating eosinophilic esophagitis (EoE), demonstrating sustained histologic and endoscopic improvements over 52 weeks. METHODOLOGY: Etrasimod, currently approved in adults with moderate to severe ulcerative colitis, blocks lymphocyte trafficking to inflamed mucosal tissues and may offer a promising option for treating […]
The post Etrasimod Shows Promise in Eosinophilic Esophagitis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-27 11:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8